Rochester, MN (KROC-AM News) - A Connecticut-based biotech company is opening an office in downtown Rochester.

BioSig Technologies is developing new devices for detecting, measuring, and recording electronic signals from the human heart to help physicians treat patients with abnormal heart rates and rhythms.

“We have been most impressed with the DMC team and their dedication to position Rochester as the world’s premier destination for health and wellness. This initiative should come as no surprise to anyone who has visited Mayo Clinic and had a privilege to work with its outstanding physician innovators, and we are honored to join the thriving life science community of Rochester,” commented Kenneth L. Londoner, Chairman and CEO of BioSig Technologies, Inc.

The biotech firm says it will use the space with the Destination Medical Center Discovery Square District for a key R&D and product development center in a strategic collaboration with the Mayo Clinic and Mayo Ventures.

The Destination Medical Center, meanwhile, has announced a firm working on medical regeneration technology has signed a lease for space in One Discovery Square. A news release says Rion LLC already has a presence in Rochester and the new offices at the Discovery Square complex signal an expansion for the company.